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The immediate progenitors of B  lymphocytes (PB  cells)  1 in  the adult  mouse 
are readily distinguishable from mature B  cells. PB cells can  be separated from 
B  cells by velocity sedimentation  cell separation  and  transplanted  into  mice 
made  immunologically incompetent  by  irradiation  (1).  The  PB  cells  cannot 
interact with antigen and thymus-dependent  lymphocytes (T cells) to give rise 
to antibody-producing cells, but within a  few days can give rise to differentiated 
progeny having this functional requirement  for being B  cells. PB  cells, in turn, 
appear to be derived from hemopoietic stem cells (2). 
Of  particular interest in  previous  studies was  the  possibility that  PB  cells 
possess  surface  immunoglobulins  (2).  Since  PB  cells are  immunologically in- 
competent when injected into irradiated mice together with antigen and thymus 
cells (T cells), this implies that acquisition of competence requires another step 
in differentiation, perhaps enabling interaction with T  cells or T  cell products. 
Nevertheless,  the  presence  of  surface  immunoglobulin  molecules  in  PB  cells 
suggests  that  cells at  this  stage  of  differentiation are  already  restricted with 
respect  to  specificity. The  work  described below is  an  attempt  to  determine 
whether PB  cells are specificity restricted. 
Materials and Methods 
Animals.--The mice used in all experiments were 8-10-wk old F1 hybrids between C57BL/6 
X  DBA/2  (BDF1) purchased  from Cumberland  View Farms (Clinton,  Tenn.).  Males were 
usually used both as recipients and bone marrow  donors, females as donors for thymus  and 
spleen cells. Mice were kept three or four to a cage after irradiation and allowed free access to 
food and water. 
Antigen.--Sheep blood (SRBC) in citrate saline was obtained weekly from Woodlyn Farms 
* This study was supported by grants from the Medical Research Council (MA-3766) and 
the National Cancer Institute of Canada. 
Recipient of a fellowship from the National Cancer Institute of Canada. Present address: 
Basel Institute of Immunology,  Basel, Switzerland. 
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(Guelph,  Ontario, Canada). The cells were washed three times in phosphate-buffered saline 
(PBS)  before use. 
Radiation.--Mice and single-cell suspensions were irradiated in a  137Cs irradiator (3)  at a 
dose rate of 102 tad/rain. Mice received 950 rad, cell suspensions 1,000 rad. Cells were irra- 
diated in an ice bath at a concentration of 108 cells/ml. 
Cell Suspensions:--Bone marrow cell suspensions were prepared by flushing 1 ml of 0.2% 
bovine serum albumin (BSA) in PBS through the femurs. Spleen, thymus, and lymph node 
cell suspensions were prepared by cutting the organ into small pieces with a pair of scissors 
and pressing the pieces through an 80 mesh stainless steel screen. All cell suspensions were 
gently pipetted and washed once; the remaining cell clumps were broken up or removed by 
filtration through a glass capillary array filter, pore size 34 #m  (Mosaic Fabrications, Stur- 
bridge,  Mass.).  All suspensions were prepared in  the cold. 
Cell Separation.--Cells were fractionated on the basis of differences in sedimentation rate 
at unit gravity, a procedure which separates cells primarily on the basis of size (4). One of two 
techniques (4,  5),  both of which give equivalent results, were used. In either case,  a  1-2% 
stabilizing gradient was used, starting cell bands were 1-4 mm wide, sedimentation time was 
4-5 h and the whole separation was performed at 4°C in a cold room. 
Antiserum.--Fluorescein-labeled anti-Ig antiserum  (Fl-anti-Ig) was a  generous gift from 
Dr. E. Unanue. In the sedimentation experiments, the cells were exposed to the labeled anti- 
serum before separation to ensure that all cells were exposed to identical labeling conditions. 
The suspension of cells  was incubated for 3  h  at 0°C with the labeled antiserum, washed 
three times with 0.23 BSA in PBS, and then introduced into the separation chamber. The 
cells were allowed to sediment for 4 h at 4°C, and fractions were collected and scored for the 
percent of cells  showing a  ring-type fluorescence.  At least 200  cells  were  scored  for  each 
fraction. 
Functional Assays.--All  functional assays are  based  on  transplantation experiments in 
which the quantity measured is the number of 19S antibody-producing ceils as determined 
by the Jerue plaque-folming cell  (PFC) assay (6). All the assays are designed in such a way 
that only B cells or their precursors limit the response obtained, i.e.,  the response is a linear 
function of the number of B  cells or PB  cells assayed. The conditions have been described 
previously (1). Briefly, B cells are defined as those cells giving rise to a detectable number of 
PFC within 8 days after immunization. A suspension to be tested for B cell activity is mixed 
with 5 X  l0  T thymus cells  (to provide excess T  cells),  and the mixture is injected into irra- 
diated recipients. Within 2 h  of injection, 5 )<  l0  T irradiated spleen cells  (to provide excess 
accessory or A cells [7]) and 108 SRBC are injected intraperitoneally. 8 days later the number 
of PFC per spleen are determined. 
By definition, PB  cells  are inactive in the assay for B  cells.  Howeve  U if an interval of 
several days is allowed to elapse between transplantation and immunization, PB  cells  dif- 
ferentiate into B  cells that can be detected by immunization. Therefore, we have defined as 
PB cells any cells that give rise to functional B cells within 7 days after transplantation into 
an irradiated recipient. Thus, the assay for PB cells is identical with the one for B cells except 
that in  the former 7  days elapse between transplantation and immunization while in  the 
latter the interval is only 2 h. Under the conditions of the assay for lPB cells,  the PFC re- 
sponse is a linear function of the number of cells injected. 
RESULTS 
Direct Measurement  of Sedimentation  Profile  of Immunoglobulin-Containing 
Cells in Bone Marrow, Spleen, and Lymph Node.--Previous characterization of 
the precursors of B  cells sensitive to SRBC indicated that these cells sediment 
faster than  the mature B  cells specific for SRBC  (1).  Further work indicated 956  CHARACTERIZATION  OF  PRECURSORS  OF  B  CELLS 
that both B lymphocytes and PB cells probably have surface immunoglobulin 
receptors (2). These two results can be directly verified by measuring the sedi- 
mentation distribution of cells stained with Fl-anti-Ig. Fig. 1 a shows, for bone 
marrow,  the  sedimentation  distribution  of  stained  cells.  As  expected,  the 
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FIG.  1.  Sedimentation profile of bone marrow  (a),  spleen  (b),  and  lymph node  (c)  cells 
stained with Fl-anti-Ig. Cells at 10 ~ cells/ml were incubated for 1-3 h at 0°C with Fl-anfi-Ig, 
then washed three times in 0.2% BSA and resuspended at 5 X  10  6 cells/ml for fractionation. 
The sedimentation time varied from 4 to 12 h and individual fractions were scored for fluores- 
cent cells (e). The nucleated cell profile (solid line) is shown only for lymph node. 
majority of the activity is found in the region of small lymphocytes where, by 
functional assays, B  cells  are known to sediment (8). The peak of fluorescent 
cells at 2.0 mm/h is the result of nonspecific uptake by damaged cells  (9) that 
sediment in this region of the gradient (8). In addition to the small peak in the 
region of slowly sedimenting cells, the main peak has a distinct shoulder (indi- 
cated by the arrow) that skews the distribution toward the rapidly sedimenting 
cells.  If one assumes a gaussian distribution for B  cells and subtracts this dis- 
tribution from the measured distribution of labeled cells,  the residual popula- 
tion (the one giving rise to the shoulder) has a modal sedimentation velocity of L.  LAFLEUR, R.  G.  MILLER, AND R.  A.  PHILLIPS  957 
about 4.8 mm/h and constitutes about 5-10 % of the total cells stained with F1- 
anti-Ig. One interpretation  of this  shoulder is that it represents  PB  cells  that 
have been shown by functional  assays  to sediment  at 5  mm/h  and probably 
have IgM molecules on their surface (1, 2). 
The shoulder could be an artifact of the separation procedure. For example, 
B cell doublets would sediment in this position (8). However, this explanation is 
unlikely  since  the  measured  frequency of doublets  was  too low  to cause  the 
shoulder. 
In an attempt to strengthen the correlation between PB cell activity and the 
presence of rapidly sedimenting immunoglobulin-bearing cells, we measured for 
spleen and lymph node the sedimentation profiles of PB cells and B  cells meas- 
ured by their activities in functional assays and of Fl-anti-Ig-staining cells. For 
both spleen  (Fig. 2)  and lymph node (Fig. 3), B  cells ( •  sediment as a single 
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Fie. 2. Sedimentation profile of PB cells and B cells in spleen. 5 X  106 spleen cells sus- 
pended in 100 ml of 0.2% BSA were separated  by velocity sedimentation for 4 h. Nucleated 
cells (solid line) were counted  in each fraction.  Pairs  of adjacent  fractions were tested  for 
B cells (•) and PB cells (©) as described in the text. 958  CHARACTERIZATION OF  PRECURSORS OF  B  CELLS 
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FIG. 3. Sedimentation profile of PB ceils and B cells in lymph node. Sedimentation condi- 
tions were identical with  those described in Fig. 2.  The figure shows the distributions  of 
nucleated cells (solid line), B cells (e), and PB cells (O). 
narrow band with a sedimentation  velocity of 3.0 mm/h. Under the conditions 
of the PB assay (O) both tissues again show the B  cells initially present at 3.0 
ram/h;  this  observation was  expected  since  the  PB  cell  assay  also detects  B 
cells (1, 2). The suspension of spleen cells also shows another peak of activity at 
5.0 mm/h. This peak by definition represents PB cells. Lymph node, however, 
does not show a peak of activity in the PB cell region and, therefore, presum- 
ably contains few, if any, PB cells. 
From these results,  we would predict  that the profile of spleen  cells stained 
with Fl-anti-Ig should be similar to one for the bone marrow cells, whereas the 
distribution of stained lymph node cells should be symmetrical with no shoulder 
in the region of the rapidly sedimenting cells. Figs. 1 b and c verify this predic- 
tion. The sedimentation profile of labeled spleen cells (Fig. 1 b) has a significant L.  LAFLEUR,  R.  G.  MILLER,  AND  R.  A.  PHILLIPS  959 
shoulder between 4.5  and 5.0 mm/h. The total number of stained cells  at 4.5 
mm/h is about 20 % of that at 3.0 ram/h, both in bone marrow and in spleen. 
A similar analysis for lymph node cells gives no indication for such a population 
in the region of PB cells; the number of stained cells at 4.5 mm/h is less than 
5 %  of that at 3.0 mm/h. Because the fluorescein-labeled cells sedimenting at 
4.5-5.0 mm/h have the same sedimentation and tissue distribution as PB cells 
measured with functional assays, we have tentatively identified this population 
as PB cells and have used this observation to estimate the absolute frequency 
of both B  cells and PB cells in bone marrow, spleen, and lymph node. These 
data (Table I) show that in both bone marrow and spleen PB cells are about 
10-fold less frequent than B cells. 
Frequency and Specificity  of PB.--The data in the previous section indicate 
that in bone marrow, PB cells occur in a relatively high frequency, about 1 per 
100 nucleated cells. If it is assumed that the antiserum detects the entire popu- 
TABLE  I 
Frequency  of PB and  B  Cells in  Various  Lymphoid  Tissues 
Tissue 
no. of cells/lO  3 nucleated cells 
B cells*  PB cells* 
Bone marrow  140  13 
Spleen  500  32 
Lymph node  250  <2 
* These numbers were derived from  the sedimentation distribution of Fl-anti-Ig as de- 
scribed in the text. 
lation of PB cells,  it is possible to estimate specificity restrictions among this 
population by looking at the frequency of cells that respond to a specific anti- 
gen. To estimate this frequency using SRBC as antigen, a standard assay for 
PB cells was carried out, using varying numbers of cells from bone marrow. To 
eliminate the background resulting from mature B  cells, the initial suspension 
of  bone  marrow  was  separated  by  velocity sedimentation.  All  of  the  cells 
sedimenting faster  than 4.5  mm/h  were pooled and  used  as  a  source of PB 
cells.  From the data shown in Figs.  1-3,  this pool (the PB  cell pool) should 
contain the majority of the PB cells and few B cells. At the completion of the 
assay, each group of mice was scored for responders and nonresponders. Any re- 
cipient giving a PFC response  >_  200 PFC/spleen was counted as a responder. 
The selection of this value was somewhat arbitrary. Because of the 15 day in- 
terval between transplantation and the assay for PFC, it was not possible to 
look at PFC responses in mice that received only thymus cells. The mortality 
in such groups was too high to obtain meaningful data. However, in several ex- 
periments, it appeared that there was a clear distinction between mice that had 960  CHARACTERIZATION  OF  PRECIJRSORS  OF  B  CELLS 
fewer than 200 PFC/spleen and those that had more. There were relatively few 
mice that gave responses between 200 and 400 PFC/spleen. 
The frequency of responders as a function of the number of cells injected from 
the PB cell pool is shown in Fig. 4. The data fit closely to the solid line that was 
calculated assuming  a  single-hit poisson distribution with  a  frequency of one 
active cell per 4.9  X  10 ~ cells injected (10). This estimated frequency must be 
corrected for two factors that  alter the actual frequency.  First, the measured 
frequency must be corrected for the enrichment resulting from the separation 
procedure. The PB cell pool contains 50 %  of the cells in the original suspension 
and almost all the PB cells so that the PB cell detection frequency is about 1 per 
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FIG. 4. Measurement of the frequency  of PB cells in bone marrow by a limiting dilution 
assay. A suspension of cells emiched for PB cells as described  in the text was assayed for 
PB cell activity under the standard conditions. The (e) give the percent of responding  mice 
(response >  200 PFC/spleen) at each dose of bone marrow  ceils injected. The solid llne is 
the expected distribution assuming an activity of one functional PB cell per 4.9 X  105 bone 
marrow cells injected. This interpretation assumes that the active unit is a single cell. 
106  unfractionated bone marrow  cells. Second, in transplantation assays, it is 
necessary to correct for the fact that only a  fraction of the injected cells will 
settle in the spleen and be subsequently detected. The standard procedure for 
estimating  this  fraction  was  described by  Sirninovitch  et  al.  (11).  Following 
their protocol, mice were given cells from the PB  cell pool. 2 h  after injection, 
these  receipients were  sacrificed  and  a  cell was  suspension  made  from  their 
spleens. This suspension was then also assayed for its content of PB cells using 
the standard assay. By comparing the PB cell activity in this group of mice with 
the PB  cell activity in the initial suspension, one can estimate the fraction of 
cells that settle in the spleen and are detected in the assay. The data in Table II 
indicate this to be approximately 14 %; using this value to correct for the fre- 
quency  of cells actually detected,  we  estimate  that  in  bone  marrow  the fre- 
quency of PB cells giving rise to progeny that react with SRBC is 7 per 106 bone L.  LAFLEUR,  R.  G.  MILLER~  AND  R.  A.  PHILLIPS  961 
marrow cells injected. These data suggest that the PB  cells specific for SRBC 
constitute approximately 0.05 %  of the total PB cell population as detected by 
the fluorescent antiserum and imply that PB cells are restricted in specificity. 
Differentiation of PB into B cells.--PB and B  cells both have immunoglobulin 
molecules on their surface and both  are apparently already restricted in their 
capacity to respond to specific antigens. However, they differ in two important 
aspects.  First, B  cells but not PB  cells can interact with T  cells to give func- 
tional PFC 8 days later, and second, they differ in size as shown by their differ- 
TABLE II 
Proportion  of  Injected  Calls Trapped in  the  Spleen 
Recipient  Source of cells  no. of cells  injected  PFC/spleen*  Relative activity 
Primary  PB cell pool:~  2 X  107  5,760§  1.00 
(4,660-7,020) 
Secondary  Spleen from primary[i  Cells from 1//44  211  0.14  4-  0.056¶ 
recipient, 2 h after  spleen  (152-296) 
injection of PB cell 
pool 
* PFC/spleen in the recipient. The values in parentheses show one standard error on each 
side of the mean. 
:~ Cells from a pool of bone marrow sedimenting faster than 4.5 mm/h. 
§ Estimated from a titration of PB cell pool. The measurement of PB activity was made 
of the range of 2.5 X  104 to 2 X  106 cells and showed an activity of 288 PFC/10  G  cells in- 
jected. Assuming  a  linear extrapolation, 2 X  107 cells would give 5,760 PFC/spleen from 
PB cells. 
H  Some primary recipients  were  sacrificed  2  h  after  transplantation and  their  spleens 
assayed for PB activity by injection into other irradiated recipients. 
¶ The PB  activity in the spleen of the primary recipient divided by the PB activity in 
the initial suspension is a measure  of the proportion of PB trapped in the spleen of the pri- 
mary  recipient.  (211 X 4)  +  5,760 =  0.14.  (Standard  error =  0.056.) 
ent sedimentation velocities and similar densities. From the measured physical 
properties one can estimate that B  cells have a volume of 170 ~m  3 and PB cells, 
370/~m  ~ (4). Because of these large differences in size, it is of interest to determine 
the  physical properties of  the newly produced  B  cells. Do B  cells change  in 
volume before they acquire the capacity to differentiate into PFC  or do they 
become functional B  cells before they decrease to the volume of mature B  lym- 
phocytes? 
To answer this question we measured, at different times after transplantation 
of PB cells, the sedimentation velocity of cells showing B  cell activity. A group 
of 30 mice received 2  X  107 cells from the stem cell pool of bone marrow  pre- 
pared as described above. At varying times after injection, four mice were sacri- 
ficed and  a  cell suspension was prepared from their spleens and separated by 962  CHARACTERIZATION  OF  PRECURSORS  OF  B  CELLS 
velocity sedimentation into two fractions: a B cell pool (2.0-4.5 mm/h) and a 
PB cell pool (4.5-8.0 ram/h). Estimates of B cell activity for each fraction were 
made using the standard assay for B  cells.  Fig. 5 shows the proportion of ac- 
tivity in each pool at various times after transplantation of the stem cell frac- 
tion. On day 7, the majority of the cells with activity in the assay for B cells are 
in the rapidly sedimenting pool, indicating they are much larger than mature B 
cells. By day ll, the activity in the two pools is about equal, and by day 20, the 
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FIO. 5. Time kinetics of the transition of PB cells to B  cells. A group of mice was given a 
large number of bone marrow cells enriched for PB cells and depleted of B  cells. At increasing 
time after  transplantation  small groups were  taken and  their  spleens were fractionated  by 
sedimentation velocity and assayed for the proportion  of the total B  cell activity present in 
the large cells (11--11)  or the small cells (O  O). 
majority of the B  cell activity is in the slowly sedimenting pool. Thus, while 
newly produced B cells have the capacity to interact with T cells and to initiate 
a PFC response, they are physically distinct from mature B lymphocytes. 
DISCUSSION 
Previous studies using  a functional assay for PB  cells suggested that  they 
have immunoglobulin molecules on their surface (2). The above studies with a 
multispecific, fluorescein-labeled anti-immunoglobulin antiserum revealed a dis- 
tinct population of stainable cells with properties similar to PB cells. Thus, there 
is a population of stainable cells in bone marrow and spleen that sediment at 1 g 
with  a  velocity of 4.5-5.0 mm/h. No rapidly sedimenting, staining cells were L.  LAFLEUR,  R.  O.  MILLER~  AND  R.  A.  PHILLIPS  963 
identified  in cell suspensions from lymph node.  Because these properties and 
tissue distribution are the same as those determined by functional tests for PB 
cell activity, we have assumed that the antiserum binds to PB  cells and that 
enumeration of staining cells with the sedimentation velocities in excess of 4.5 
mm/h gives an estimate of the total number of PB cells. 
Comparison of  the  total  number of PB  cells with  the  number  specific for 
SRBC  suggests that PB  cells are restricted  in  their capacity to respond to a 
specific antigen. For example, PB cells in bone marrow occur with a frequency of 
1,300 per 105 nucleated cells (Fig. 1 and Table I). This estimate, based on stain- 
ing with Fl-anti-Ig, is assumed to include all of the PB cells in bone marrow. By 
a limiting dilution method the frequency of PB  cells active in the assay with 
SRBC as antigen is 0.7/105. Thus, the assay with a specific antigen detects only 
0.05 % of the total PB cells estimated to be present in bone marrow. If PB cells 
are restricted and each specificity is represented with the same frequency as the 
one for SRBC, one would predict 1,000 different PB cells representing different 
specificities.  Because  SRBC  are  complex  antigens,  this  calculation  probably 
underestimates by at least a factor of 10 the actual number of different PB cells. 
However, in view of this probable restriction, PB cells should not be called stem 
cells since this term connotes pluripotentiality (11). 
It is interesting to note that B cells appear to show a similar degree of speci- 
ficity restriction. Again, in bone marrow the frequency of total B  cells is 1/10, 
while the frequency of B cells specific for SRBC is 1/104  (12). As with PB cells, 
specific B  cells represent only a  small fraction, 0.1%,  of the total B  cell  pool. 
Thus, we would conclude that both PB and B cells show similar restrictions in 
their capacity to respond to specific antigens. 
The suggestion that PB cells are restricted in specificity implies that the im- 
munoglobulin molecules on the membrane of PB cells (2) are specific receptors 
for the antigen to which their progeny B  cells will respond. In this case, how- 
ever, one would expect PB cells to form rosettes when they interact with SRBC. 
The data on this point are inconclusive. Studies on the sedimentation properties 
of rosette-forming cells (RFC)  in both spleen and bone marrow give no indica- 
tion of RFC among the population sedimenting at 5.0 mm/h (8).  However, the 
density profile of RFC  reveals a  small population  of RFC  in  the region now 
known to contain PB cells (13). 
Another indirect indication of the specificity of PB cells comes from the anti- 
gen suicide experiments of Unanue (14). He incubated bone marrow cells with 
radioactive antigen,  transplanted  the population into irradiated  animals,  and 
then at a later time tested the immune response to the original antigen and to a 
non-cross-reacting antigen. He observed specific suppression to the antigen la- 
beled with 125I indicating that some cells in bone marrow specifically bind anti- 
gen and are destroyed by the radioactive decay of the labeled antigen.  It ap- 
pears that under the condition of his assays much of the immune response would 
be derived from the differentiation of PB  cells,  and we would interpret his re- 
sults as evidence for the specificity of PB cells as well as B cells. 964  CHARACTERIZATION  OF  PRECURSOI~S  OF  B  CELLS 
At the present time, one can only speculate about the precise physiological 
role for PB cells, but there are two obvious possibilities for their function. First, 
cells such as PB cells that occur in a relatively low frequency provide a readily 
available source for new B cells.  Second, generation of antibody specificity may 
occur at the level of PB cells.  For example, since they apparently have specific 
surface receptors but do not respond by the immediate production of antibody, 
they could  be the  stage  at  which  specificities to  self-antigens  are  eliminated. 
That is, it is possible that exposure of PB cells to antigen could induce tolerance, 
preventing the development of "forbidden clones" (15). 
Since PB cells are the immediate progenitors of B cells,  it is perhaps not sur- 
prising that the newly produced B cells have physical properties more similar to 
PB  cells than to mature B  cells.  However, it is important to note that, as de- 
fined by a  functional  assay, intermediate B  cells are different from mature B 
cells and should be distinguished in studies on the differentiation of B lympho- 
cytes. We propose that these transitional B cells be designated B1 and the ma- 
ture form B2. The precise relationship between B1 and B2 cells is not clear. On 
the basis of the kinetic data shown in Fig. 5, it appears that B1 is a progenitor 
of B2 • 
Table III gives a summary of some of the known properties of the cells thought 
to be involved in  the pathway of  differentiation of antibody-producing cells. 
For reasons described previously, it is probable that the  pluripotent  stern  cell 
for  the  immune  system is  identical  with  the  cell  that  forms  colonies  in  the 
spleens  of irradiated  mice  (CFU-S).  Although  very little  is  known  about B1 
cells,  they can be distinguished from PB  and B2 cells by two properties: their 
sedimentation velocity and their  ability to initiate an imnmne response. With 
the accumulation  of other physiological measurements, it will  undoubtedly be 
necessary to  subdivide  the B  lymphocyte pool  into  other  categories.  For ex- 
ample, Playfair and Purves (16) have shown that some B lymphocytes can initi- 
ate an immune response in the absence of added T  lymphocytes. It is not clear 
TABLE  III 
Summary  of Some  of tile Properties  of the Cells along the Di~erentiation  Pathway to 
Small Lymphocytes 
Sedimentation  Surface  Capacity to  Secrete 
Cell type  velocity  immunoglobulin  Bind antigen  initiate PFC  antibody 
response 
mm/h 
CFU-S  4.0  ?*  N.D.:~  No  No 
PB  5.0  Yes  ?  No  No 
B1  >4.5  N.D.  N.D.  Yes  No 
B 2  3.0  Yes  Yes  Yes  No 
PFC  4.5  No  No  No  Yes 
* Equivocal results, see Discussion section. 
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where  these  lymphocytes fit into  the  proposed pathway of differentiation  in 
which PB cells give rise to B1 that in turn differentiate into B2. 
Although this paper is not concerned with the properties of T  lymphocytes, 
the sedimentation distribution shown in Fig. 1 c gives information about the T 
lymphocytes in lymph node. Since T  cells do not contain easily detectable im- 
munoglobulins on their surface (9), the unstained lymphocytes are presumably 
thymus derived.  The unstained  lymphocytes sediment more rapidly than the 
stained lymphocytes, indicating that T cells have a higher sedimentation velocity 
than  B  cells.  From  the  data in  Fig.  1 c,  one can estimate the sedimentation 
velocity of T  cells to be 3.5 mm/h. This estimate is in contrast to our previous 
report of a sedimentation velocity of 3.0 mm/h for both T  and B  lymphocytes 
(8).  The probable reason for this  discrepancy lies in  the  different  tissues  ex- 
amined in the two studies. In the previous report, the sedimentation velocity of 
T cells was measured directly only in thymus tissue; no measurements of T cells 
were made in peripheral lymphoid tissues such as spleen or lymph node. On the 
basis of the previous results and the results presented here, we tentatively con- 
clude that the T  cells in thymus have a  slightly lower sedimentation velocity 
than the T  cells found in peripheral lymphoid tissues such as spleen or lymph 
node. This conclusion is more in agreement with  those of Osoba who, using a 
sensitive in vitro assay, found that T  cells in spleen sediment at 4.0 mm/h (17). 
SUMMARY 
Previous work has shown  that  the immediate precursor of B  lymphocytes 
(PB cell) has many properties that distinguish it from both B lymphoctes and 
hemopoietic stem cells.  Size,  density, tissue distribution,  and sensitivity to cy- 
totoxic antisera differ for each type of cell.  The work described here was de- 
signed to study three aspects of the differentiation of PB cells.  First, since PB 
cells probably have immunoglobuIin surface receptors, fluorescein-labeled anti- 
immunoglobulin antiserum was used in an attempt to investigate directly the 
physical properties of PB  cells.  The use of this  labeled  antiserum  revealed a 
population of cells with properties similar to the PB cells defined by the func- 
tional assays. Second,  the differentiative potential of PB  cells was studied  by 
comparing  the  size  of  the  total  population  of  PB  cells,  as  determined  with 
fluorescein-labeled anti-immunoglobulin antiserum, to the size of the population 
of PB  cells responding in a functional  assay with a  specific antigen.  The cells 
responding in the functional assay represent only 0.1% of the total population 
of PB  cells.  This observation suggests that PB  cells are not pluripotent stem 
cells of the immune system. Finally, the kinetics of the differentiation of PB cells 
to B  lymphocytes was studied.  The differentiation to mature lymphocytes in- 
volves at least one intermediate stage in which cells larger than mature B cells 
are active in a functional assay for B cells.  These large B cells are present in ir- 
radiated mice soon after transplantation of PB cells, but by 20 days the majority 
of the B cells are typical small lymphocytes. 966  CHARACTERIZATION OF  PRECURSORS OF  B  CELLS 
Excellent technical help was provided by R. Kuba, J. Madrus, and H. Renwick.  Dr. E. 
Unanue  generously  provided  the  fluorescein-labeled  anti-Ig  antiserum. 
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